The Pharmacy Times® Women's Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health conditions that affect women, including gynecological health and maternal health.
April 14th 2025
Promoting weight management prior to pregnancy and in early life may yield stronger cardiovascular and maternal health.
FDA Approves Pembrolizumab for Relapsed/Refractory PMBCL, Advanced Cervical Cancer
June 14th 2018Officials with the FDA have granted accelerated approval to pembrolizumab (Keytruda, Merck) for 2 new indications, including the treatment of refractory primary mediastinal large B-cell lymphoma (PMBCL), and recurrent metastatic cervical cancer in previously treated patients whose tumors express PD-L1.
Read More